Illumina 18 avr. 2026 Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Major Pediatric Genomics Partnership - simplywall.st
Illumina 16 avr. 2026 DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire
Illumina 16 avr. 2026 Robeco Institutional Asset Management B.V. Trims Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
PerkinElmer 15 avr. 2026 Former Illumination and Detection Solutions (IDS) Business Unit of PerkinElmer is now Excelitas Technologies Corp. - LEDinside
Illumina 15 avr. 2026 Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative - Yahoo Finance
Illumina 14 avr. 2026 How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st
Illumina 14 avr. 2026 Illumina partners with D3b on pediatric genomic data initiative - Investing.com
Illumina 14 avr. 2026 Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PR Newswire
Illumina 14 avr. 2026 Illumina and Labcorp Deepen Oncology Alliance to Expand Cancer Genomic Testing Access - The Healthcare Technology Report.
Illumina 14 avr. 2026 Illumina Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily
Illumina 13 avr. 2026 Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina 13 avr. 2026 FSIS Updates Whole Genome Sequencing Laboratory Method - Quality Assurance & Food Safety
Illumina 12 avr. 2026 Does Illumina (ILMN) Now Offer Value After A 61.7% One Year Rebound? - simplywall.st